M-DDO
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Guadalajara
Overview
M-DDO is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
M-DDO clinical trials
Explore related
Medical disclaimer. This page summarizes research about M-DDO for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.